Maor M H, Frias A E, Oswald M J
Department of Clinical Radiotherapy, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Cancer. 1988 Nov 1;62(9):1912-7. doi: 10.1002/1097-0142(19881101)62:9<1912::aid-cncr2820620908>3.0.co;2-t.
Between 1968 and 1985, 46 patients with renal cell carcinoma metastatic to the brain parenchyma were treated with radiation. Thirty-nine received whole-brain radiation, mostly 30 Gy in ten fractions. Symptoms improved in 30% of evaluable patients. Partial regression of metastases was documented in two of 11 available sequential computed tomographs (CT) of the brain. Seven patients were treated with surgery and postoperative radiation. In five the excision was complete and associated with clinical improvement. All 46 patients have subsequently died. The median survival time of the entire group was 8 weeks. The ten patients who improved after radiotherapy survived for a median of 17 weeks. Two additional patients were treated in 1986 with fast neutrons; both had a documented maintained complete response. Brain metastasis in renal carcinoma carries a poor prognosis. It is usually unresponsive to conventional photon therapy. In selected cases an alternative treatment with surgery or neutron therapy should be considered.
1968年至1985年间,46例脑实质转移的肾细胞癌患者接受了放射治疗。39例接受了全脑放疗,大多为分10次给予30 Gy。30%的可评估患者症状有所改善。在11份可用的脑部连续计算机断层扫描(CT)中,有2份记录到转移灶部分消退。7例患者接受了手术及术后放疗。其中5例切除彻底并伴有临床症状改善。所有46例患者随后均死亡。整个组的中位生存时间为8周。放疗后病情改善的10例患者中位生存时间为17周。1986年另外2例患者接受了快中子治疗;2例均记录到持续完全缓解。肾癌脑转移预后较差。它通常对传统光子治疗无反应。在某些特定病例中,应考虑采用手术或中子治疗作为替代治疗方法。